ATE450549T1 - Monoklonale antikörper mit spezifität für fetale erythroidzellen - Google Patents
Monoklonale antikörper mit spezifität für fetale erythroidzellenInfo
- Publication number
- ATE450549T1 ATE450549T1 AT05736009T AT05736009T ATE450549T1 AT E450549 T1 ATE450549 T1 AT E450549T1 AT 05736009 T AT05736009 T AT 05736009T AT 05736009 T AT05736009 T AT 05736009T AT E450549 T1 ATE450549 T1 AT E450549T1
- Authority
- AT
- Austria
- Prior art keywords
- specificity
- cells
- monoclonal antibodies
- erythroid cells
- fetal
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70582—CD71
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ecology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04007811 | 2004-03-31 | ||
PCT/EP2005/003371 WO2005100401A2 (en) | 2004-03-31 | 2005-03-31 | Monoclonal antibodies with specificity for fetal erythroid cells |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE450549T1 true ATE450549T1 (de) | 2009-12-15 |
Family
ID=35150543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05736009T ATE450549T1 (de) | 2004-03-31 | 2005-03-31 | Monoklonale antikörper mit spezifität für fetale erythroidzellen |
Country Status (9)
Country | Link |
---|---|
US (6) | US7858757B2 (de) |
EP (1) | EP1732951B1 (de) |
JP (1) | JP4756032B2 (de) |
AT (1) | ATE450549T1 (de) |
AU (1) | AU2005233254B2 (de) |
CA (1) | CA2561830C (de) |
DE (1) | DE602005018028D1 (de) |
ES (1) | ES2337702T3 (de) |
WO (1) | WO2005100401A2 (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE450549T1 (de) * | 2004-03-31 | 2009-12-15 | Adnagen Ag | Monoklonale antikörper mit spezifität für fetale erythroidzellen |
US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
DE102006062619B4 (de) * | 2006-12-29 | 2012-04-26 | Medion Diagnostics Ag | Verfahren zur Bestimmung von minoren Zellpopulationen in heterogenen Zellpopulationen |
ES2620431T3 (es) | 2008-08-04 | 2017-06-28 | Natera, Inc. | Métodos para la determinación de alelos y de ploidía |
US20120185176A1 (en) | 2009-09-30 | 2012-07-19 | Natera, Inc. | Methods for Non-Invasive Prenatal Ploidy Calling |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
CA3037126C (en) | 2010-05-18 | 2023-09-12 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
TW201305200A (zh) | 2010-11-30 | 2013-02-01 | Genentech Inc | 低親和力血腦障壁受體抗體及其用途 |
JP6328934B2 (ja) | 2010-12-22 | 2018-05-23 | ナテラ, インコーポレイテッド | 非侵襲性出生前親子鑑定法 |
JP6153874B2 (ja) | 2011-02-09 | 2017-06-28 | ナテラ, インコーポレイテッド | 非侵襲的出生前倍数性呼び出しのための方法 |
US9404864B2 (en) | 2013-03-13 | 2016-08-02 | Denovo Sciences, Inc. | System for imaging captured cells |
EP2739587B1 (de) | 2011-08-01 | 2020-05-27 | Denovo Sciences | Zellerfassungssystem |
US10466160B2 (en) | 2011-08-01 | 2019-11-05 | Celsee Diagnostics, Inc. | System and method for retrieving and analyzing particles |
US9174216B2 (en) | 2013-03-13 | 2015-11-03 | DeNovo Science, Inc. | System for capturing and analyzing cells |
US20130122492A1 (en) * | 2011-11-14 | 2013-05-16 | Kellbenx Inc. | Detection, isolation and analysis of rare cells in biological fluids |
US10058306B2 (en) | 2012-06-22 | 2018-08-28 | Preprogen, LLC | Method for obtaining fetal cells and fetal cellular components |
US9752181B2 (en) | 2013-01-26 | 2017-09-05 | Denovo Sciences, Inc. | System and method for capturing and analyzing cells |
US9707562B2 (en) | 2013-03-13 | 2017-07-18 | Denovo Sciences, Inc. | System for capturing and analyzing cells |
US10391490B2 (en) | 2013-05-31 | 2019-08-27 | Celsee Diagnostics, Inc. | System and method for isolating and analyzing cells |
US9856535B2 (en) | 2013-05-31 | 2018-01-02 | Denovo Sciences, Inc. | System for isolating cells |
US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
US9499870B2 (en) | 2013-09-27 | 2016-11-22 | Natera, Inc. | Cell free DNA diagnostic testing standards |
EP3134541B1 (de) | 2014-04-21 | 2020-08-19 | Natera, Inc. | Nachweis von ploidien in chromosomalen segmenten in krebs |
US20160130553A1 (en) * | 2014-05-15 | 2016-05-12 | Kellbenx Incorporated | PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING |
US20150330979A1 (en) * | 2014-05-15 | 2015-11-19 | Kellbenx Incorporated | PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING |
EP3179248A4 (de) * | 2014-08-05 | 2017-06-14 | Fujifilm Corporation | Verfahren zur trennung von nukleierten roten blutkörperchen |
WO2016183106A1 (en) | 2015-05-11 | 2016-11-17 | Natera, Inc. | Methods and compositions for determining ploidy |
WO2018067517A1 (en) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
JP6234542B1 (ja) | 2016-12-27 | 2017-11-22 | 株式会社 TL Genomics | 胎児細胞由来染色体dnaの取得方法 |
WO2018156418A1 (en) | 2017-02-21 | 2018-08-30 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
CN112980667A (zh) | 2017-08-29 | 2021-06-18 | 伯乐实验室有限公司 | 用于分离和分析细胞的系统和方法 |
CN111247427B (zh) | 2017-10-19 | 2022-02-01 | Tl基因体科技株式会社 | 细胞分类芯片 |
US10946380B2 (en) * | 2018-01-19 | 2021-03-16 | International Business Machines Corporation | Microfluidic chips for particle purification and fractionation |
US12024738B2 (en) | 2018-04-14 | 2024-07-02 | Natera, Inc. | Methods for cancer detection and monitoring |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
US10633693B1 (en) | 2019-04-16 | 2020-04-28 | Celsee Diagnostics, Inc. | System and method for leakage control in a particle capture system |
US20230258663A9 (en) | 2019-05-02 | 2023-08-17 | Kellbenx Incorporated | Filtration-based methods for preparing fetal nucleated red blood cells (nrbcs) for diagnostic testing |
US11578322B2 (en) | 2019-05-07 | 2023-02-14 | Bio-Rad Laboratories, Inc. | System and method for automated single cell processing |
US11273439B2 (en) | 2019-05-07 | 2022-03-15 | Bio-Rad Laboratories, Inc. | System and method for target material retrieval from microwells |
JP7356519B2 (ja) | 2019-06-14 | 2023-10-04 | バイオ-ラッド ラボラトリーズ インコーポレイテッド | 自動化された単一細胞処理及び解析のためのシステム及び方法 |
US11504719B2 (en) | 2020-03-12 | 2022-11-22 | Bio-Rad Laboratories, Inc. | System and method for receiving and delivering a fluid for sample processing |
CA3230796A1 (en) | 2021-09-01 | 2023-03-09 | Biogen Ma Inc. | Anti-transferrin receptor antibodies and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10035433C2 (de) * | 2000-07-20 | 2002-07-18 | Tuma Wolfgang | Schonende Hochanreicherung von fetalen Zellen aus pripherem Blut und Verwendung derselben |
ITRM20010322A1 (it) | 2001-06-08 | 2002-12-09 | Consiglio Nazionale Ricerche | Metodo non ivasivo su sangue materno per lo screening e la diagnosi di aneuploidie fetali. |
ATE450549T1 (de) * | 2004-03-31 | 2009-12-15 | Adnagen Ag | Monoklonale antikörper mit spezifität für fetale erythroidzellen |
-
2005
- 2005-03-31 AT AT05736009T patent/ATE450549T1/de active
- 2005-03-31 US US10/599,512 patent/US7858757B2/en active Active
- 2005-03-31 AU AU2005233254A patent/AU2005233254B2/en active Active
- 2005-03-31 DE DE602005018028T patent/DE602005018028D1/de active Active
- 2005-03-31 JP JP2007505500A patent/JP4756032B2/ja active Active
- 2005-03-31 WO PCT/EP2005/003371 patent/WO2005100401A2/en active Application Filing
- 2005-03-31 CA CA2561830A patent/CA2561830C/en active Active
- 2005-03-31 ES ES05736009T patent/ES2337702T3/es active Active
- 2005-03-31 EP EP05736009A patent/EP1732951B1/de active Active
-
2010
- 2010-12-28 US US12/979,535 patent/US8536312B2/en active Active
-
2013
- 2013-09-16 US US14/028,027 patent/US9194871B2/en active Active
-
2015
- 2015-08-13 US US14/825,516 patent/US20160039932A1/en not_active Abandoned
- 2015-10-14 US US14/882,995 patent/US9453841B2/en active Active
-
2022
- 2022-11-18 US US17/989,895 patent/US20230324383A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2005100401A3 (en) | 2006-06-15 |
US20230324383A1 (en) | 2023-10-12 |
US20070275418A1 (en) | 2007-11-29 |
AU2005233254B2 (en) | 2011-11-24 |
US20160084837A1 (en) | 2016-03-24 |
EP1732951A2 (de) | 2006-12-20 |
US9194871B2 (en) | 2015-11-24 |
US20160039932A1 (en) | 2016-02-11 |
US20110129916A1 (en) | 2011-06-02 |
JP2007530629A (ja) | 2007-11-01 |
CA2561830A1 (en) | 2005-10-27 |
US20140154704A1 (en) | 2014-06-05 |
US8536312B2 (en) | 2013-09-17 |
AU2005233254A1 (en) | 2005-10-27 |
EP1732951B1 (de) | 2009-12-02 |
US7858757B2 (en) | 2010-12-28 |
JP4756032B2 (ja) | 2011-08-24 |
ES2337702T3 (es) | 2010-04-28 |
WO2005100401A2 (en) | 2005-10-27 |
CA2561830C (en) | 2013-05-21 |
US9453841B2 (en) | 2016-09-27 |
DE602005018028D1 (de) | 2010-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE450549T1 (de) | Monoklonale antikörper mit spezifität für fetale erythroidzellen | |
NZ623706A (en) | Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof | |
DK1881064T3 (da) | HCV-anti-kerne monoklonalt antistof | |
TW200616662A (en) | Humanized anti-5t4 antibodies and anti-5t4 antibody/calicheamicin conjugates | |
MY171554A (en) | Monoclonal antibody and immunoassay using the same | |
EA200971114A1 (ru) | Определение антигенов, расположенных на эритроцитах, и антиэритроцитарных антител | |
ATE464374T1 (de) | Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen | |
WO2008122793A3 (en) | Blood group antibody screening | |
WO2008025964A3 (en) | Antibodies to an epitope of agr2. assays and hybridomas | |
WO2006075142A3 (en) | FORMS OF FACTOR XIIa | |
EP1072888A3 (de) | Immunoassay-Verfahren und -Reagens für HIV-1p24-Antigen | |
MX2023004500A (es) | Anticuerpos contra el receptor beta de la oncostatina m canina y felina y usos de estos. | |
WO2005114203A3 (en) | Dominant b cell epitopes and methods of making and using thereof | |
AU2003283240A1 (en) | Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells | |
EP1879029B8 (de) | Immunnachweiskit in verbindung mit neuroglobin-enzym sowie verwendung davon | |
WO2006020263A3 (en) | Cytoxan antibodies and immunoassay | |
WO2006044888A3 (en) | Reagents for urine-based immunological assays | |
WO2007011698A3 (en) | Humanized antibody conjugates and related methods, assays, reagents, and kits | |
WO2006060188A3 (en) | Anti-tenascin monoclonal antibody immunoassays and diagnostic kits | |
WO2010053772A3 (en) | Disease-associated antigens and methods of use thereof | |
EP1359161A3 (de) | Monoklonaler Antikörper, der spezifische gegen tartratbeständige Säurephosphatase 5b gerichtet ist und dessen Verwendung | |
WO2006005940A3 (en) | Monoclonal anti-glut2 antibody | |
MX2022014580A (es) | Ensayo de multiplex doble para multiples isotipos de inmunoglobulina. | |
BR0204612A (pt) | Anticorpos monoclonais antinúcleo de hcv | |
WO2009035357A3 (en) | Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1732951 Country of ref document: EP |